CompaniesByCap
PODD
Insulet Corporation (PODD)
NASDAQ · Healthcare

Insulet Corporation Revenue 2009–2025

Insulet Corporation annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Insulet Corporation revenue for the quarter ending March 31, 2026 was 761.7 M, a 33.87% increase year-over-year.
  • Insulet Corporation revenue for the twelve months ending March 31, 2026 was 2.7 B, a 40.87% increase year-over-year.
  • Insulet Corporation annual revenue for 2025 was 2.7 B, a 30.73% increase from 2024.
  • Insulet Corporation annual revenue for 2024 was 2.1 B, a 22.07% increase from 2023.
  • Insulet Corporation annual revenue for 2023 was 1.7 B, a 60.80% increase from 2022.
  • Insulet Corporation annual revenue for 2022 was 1.1 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Insulet Corporation (PODD) — Frequently Asked Questions

Insulet Corporation (PODD) is a publicly traded US company. It has a market capitalization of $10.83B. In fiscal 2025 it reported revenue of $2.71B and net income of $247M. Explore PODD's stock price, financial statements, earnings history, margins and key ratios below.

What is Insulet Corporation's market cap?

Insulet Corporation (PODD) has a market capitalization of $10.83B.

What is the PODD stock price?

PODD trades at $150.71 (-5.58% on the day).

How much revenue does Insulet Corporation make?

Insulet Corporation reported revenue of $2.71B in fiscal 2025.

Is PODD profitable?

In fiscal 2025, Insulet Corporation reported net income of $247M.